Sividon Diagnostics sividon.com


Sividon Diagnostics develops breast cancer prognostic tests. Sividon's core EndoPredict product is a kit-based RNA expression test designed to assess the aggressiveness of breast cancer on a molecular level through the evaluation of 12 genes.

Sividon Diagnostics develops breast cancer prognostic tests. Sividon's core EndoPredict product is a kit-based RNA expression test designed to assess the aggressiveness of breast cancer on a molecular level through the evaluation of 12 genes.

Company (Acquired)

Phone: +49 221 669 561 00

Fax:

Nattermannallee 1

Cologne, 50829
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sividon Diagnostics $0.1M May 31, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sividon Diagnostics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.